Trial intelligence / Profile preview

Probiotics vs Antibiotics in Chronic Periodontitis

NCT03692819Completed

Sponsor
Universidade Estadual Paulista
Start
May 2018
Primary completion
Aug 2020
Modality
Live Biotherapeutic Products
Countries
1
01

Overview

Randomised, double-blind trial of lactobacillus reuteri in chronic periodontitis (3 arms), sponsored by Universidade Estadual Paulista. Primary endpoint: Probing Depth change at 90 days. Started May 2018; status: completed.

02

Drugs

lactobacillus reuteri
03

Conditions

chronic periodontitis

Beyond the preview

Go deeper on NCT03692819.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03692819.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call